Skip to main content
44°
Clear
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
News
Local News
State News
Sports
Local Sports
Pro Sports
Lifestyle
Local Entertainment
Multimedia
Community Choice
Features
Special Sections
Local Events
Weather
Classifieds
Place Ad
Legal Notices
Place Call Legal
Search Call Legals
Place Times Legal
Search Times Legals
Public Notices
Obituaries
E-Edition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about SPRY
Recent news which mentions SPRY
12 Health Care Stocks Moving In Thursday's Intraday Session
March 20, 2025
Tickers
ADAP
AKBA
BDRX
CRVO
Tags
CRVO
ADAP
SPRY
From
Benzinga
Jabil Posts Better-Than-Expected Earnings, Joins Darden Restaurants, QXO, Five Below And Other Big Stocks Moving Higher On Thursday
March 20, 2025
Tickers
CAPR
CLEU
CVNA
DRI
Tags
Movers
CLEU
CVNA
From
Benzinga
Earnings Scheduled For March 20, 2025
March 20, 2025
Tickers
ACN
ADAP
ALAR
AMPX
Tags
IFRX
GAMB
ASO
From
Benzinga
FDA Approves ARS Pharmaceuticals' Lower Dose Neffy Nasal Spray For Emergency Allergy Treatment
March 06, 2025
Tickers
NEWS
SPRY
Tags
Health Care
Briefs
General
From
Benzinga
Earnings Scheduled For November 13, 2024
November 13, 2024
Tickers
ACXP
ADAP
AEMD
AFCG
Tags
AEMD
SCWO
BWEN
From
Benzinga
Insights Ahead: ARS Pharmaceuticals's Quarterly Earnings
November 12, 2024
Tickers
SPRY
Tags
SPRY
Market News
BZI/EP
From
Benzinga
ARS Pharmaceuticals Inks Licensing Pact For Neffy Allergic Reaction Treatment, Analyst Sees Further Stock Upside Despite 200% Surge In 2024
November 11, 2024
Tickers
NEWS
SPRY
Tags
Market News
General
Briefs
From
Benzinga
Where ARS Pharmaceuticals Stands With Analysts
October 08, 2024
Tickers
SPRY
Tags
SPRY
Benzinga
Analyst Ratings
From
Benzinga
Analyst Ratings For ARS Pharmaceuticals
September 09, 2024
Tickers
SPRY
Tags
SPRY
Analyst Ratings
Benzinga
From
Benzinga
Newly Approved ARS Pharmaceuticals' Needle-Free Neffy Offers Convenience Over EpiPen For Allergic Reaction, But Real-World Efficacy Questioned
August 23, 2024
Tickers
NEWS
SPRY
Tags
Top Stories
News
Market News
From
Benzinga
ARS Pharmaceuticals 'Neffy Uniquely Positioned With Potential To Change Allergy Treatment Paradigm For First Time In 40 years:' Analyst
August 20, 2024
Tickers
NEWS
SNY
SPRY
Tags
SPRY
Analyst Ratings
why it's moving
From
Benzinga
Fabrinet Posts Strong Earnings, Joins Amer Sports, Hawaiian Holdings And Other Big Stocks Moving Higher On Tuesday
August 20, 2024
Tickers
AS
BTBT
FN
HA
Tags
HA
AS
Market News
From
Benzinga
Looking Into ARS Pharmaceuticals's Recent Short Interest
August 19, 2024
Tickers
SPRY
Tags
Market News
Benzinga
Trading Ideas
From
Benzinga
Loar Holdings Posts Upbeat Results, Joins Nvidia, Clean Energy Fuels, Penumbra And Other Big Stocks Moving Higher On Tuesday
August 13, 2024
Tickers
AILE
ASND
CLNE
CLVT
Tags
SBUX
ASND
CVNA
From
Benzinga
FDA Approves ARS Pharma's Once Rejected Neffy Nasal Spray Alternative To EpiPen For Emergency Allergy Treatment
August 09, 2024
Tickers
NEWS
SNY
SPRY
Tags
Market News
Movers
Briefs
From
Benzinga
SPRY Stock Earnings: ARS Pharmaceuticals Meets EPS for Q1 2024
May 09, 2024
Tickers
SPRY
Tags
SPRY
Market News
Earnings Reports
From
InvestorPlace
Top 5 Health Care Stocks That May Plunge In March
March 28, 2024
Tickers
INZY
MESO
NEWS
PNTG
Tags
Pre/Market Outlook
MESO
STIM
From
Benzinga
SPRY Stock Earnings: ARS Pharmaceuticals Beats EPS for Q4 2023
March 21, 2024
Tickers
SPRY
Tags
SPRY
Today's Market
Market News
From
InvestorPlace
Wall Street Favorites: 3 Under-$10 Stocks with Strong Buy Ratings for March 2024
March 15, 2024
Tickers
ENFN
SOUN
SPRY
Tags
NASDAQ:SOUN,NYSE:ENFN,NASDAQ:SPRY
ENFN
Stocks to Buy
From
InvestorPlace
Allergic Reaction Focused ARS Pharmaceuticals' Lead Candidate Shows Efficacy In Skin Disorder
February 26, 2024
Tickers
NEWS
SPRY
Tags
General
Briefs
Health Care
From
Benzinga
ARS Pharma Readies Data In Response To FDA's Rejection For Its EpiPen Alternative For Severe Allergic Reactions
February 20, 2024
Tickers
NEWS
SPRY
Tags
Market News
General
Briefs
From
Benzinga
Why Wynn Resorts Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Friday's Mid-Day Session
November 10, 2023
Tickers
AAOI
ACB
ADPT
AERT
Tags
SPRY
TTD
AFRM
From
Benzinga
Big Stocks Moving Higher On Friday: Synaptics Reports Q1 Beat; Joins Lyft, Hologic, Blink Charging
November 10, 2023
Tickers
ALRM
AVPT
BLNK
CWCO
Tags
DOCS
Movers
CWCO
From
Benzinga
Why TD SYNNEX Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
September 26, 2023
Tickers
ACON
ACST
ADPT
AFIB
Tags
NVOS
RNAZ
SLNO
From
Benzinga
Fisker, Intercept Pharmaceuticals, Immunovant And Other Big Stocks Moving Higher On Tuesday
September 26, 2023
Tickers
ADPT
ARQT
BLUE
FSR
Tags
SPRY
NKLA
BLUE
From
Benzinga
More Than $8M Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying
September 26, 2023
Tickers
CXDO
KIRK
SOL
SPRY
Tags
Penny Stocks Insider Buying
Market News
KIRK
From
Benzinga
ARS Pharmaceuticals' EpiPen Alternative Delayed US Approval - Two Analysts Offer Differing Views
September 21, 2023
Tickers
SPRY
Tags
News
Small Cap
Analyst Color
From
Benzinga
What's Going On With ARS Pharmaceuticals Stock Today?
September 21, 2023
Tickers
SPRY
Tags
why it's moving
SPRY
News
From
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
September 21, 2023
Tickers
AIMD
AVGR
BFLY
CALT
Tags
EVAX
SPRY
SEEL
From
Benzinga
Gold Moves Higher; Fed Leaves Key Overnight Interest Rate Unchanged
September 20, 2023
Tickers
CATC
FRTX
ICCM
SCS
Tags
Global
Market News
ICCM
From
Benzinga
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.